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It is now well established that mutational activation of the Ras gene is a key event in human cancer development (Lowy and Willumsen, 1993; Bos, 1997; Campbell et al., 1998; Downward, 1998) . Oncogenic Ras proteins transform cells via multiple downstream signaling cascades including Raf/MEK/ERK MAPK and phosphoinositide 3-kinase (PI3-K)/AKT kinase pathways. Raf/MEK/ERK MAPK is one of the best-characterized Ras-regulated signaling pathway and activation of this kinase cascade leads to the phosphorylation and activation of pro-proliferative transcription factors, such as Elk-1, Ets-2 and c-Myc (Marshall, 1999; Cox and Der, 2003; Downward, 2003) . Inhibition of Raf/MEK/ERK pathway suppresses Ras-mediated transformation, indicating that this pathway plays a major role in this transformation process. PI3-K/AKT kinase-regulated pathway is another important Ras effector signaling pathway. Activation of this pathway generally involves PI3-K-dependent phosphorylation of the inositol lipids to generate PI(3)P, PI(3,4)P 2 and PI(3,4,5)P 3 in order to activate the downstream target kinases, such as PDK and AKT(reviewed in Bos, 1995; Scheid and Woodgett, 2001; Cantley, 2002; Vivanco and Sawyers, 2002) . The activated Akt phosphorylates a wide range of downstream substrates, many of which are involved in the regulation of cell survival, cell cycle progression and cell metabolism (reviewed in Hemmings, 1997; Datta et al., 1999) . Like the Raf/MEK/ERK pathway, inhibition of the PI3-K/AKT pathway reduces Ras-induced transformation (Sheng et al., 2001) , suggesting that activation of PI3-K/Akt pathway is also required for transformation.
Oncogenic Ras has also been shown to downregulate the expression of proapoptotic proteins, including Bcl2 family protein Bak and transcriptional repressor Par-4 (Rosen et al., 1998; Barradas et al., 1999; Nalca et al., 1999; Qiu et al., 1999) . Thus, Ras-induced transformation is also believed to involve Ras-mediated downregulation of proapoptotic proteins. Transcription factor Gadd153 (Growth Arrest and DNA Damage 153), also known as CHOP (Luethy et al., 1990; Ron and Habener, 1992) , is believed to function as a proapoptotic molecule. Gadd153 belongs to the C/ EBP (CCAAT/enhancer binding protein) family of transcription factors. It forms heterodimers with other C/EBP family proteins and alter their transcriptional activities (Ron and Habener, 1992; Ramji and Foka, 2002) . Gadd153 is ubiquitously expressed at a relatively low level (Ron and Habener, 1992) in several cell types (Jousse et al., 2001 ) and its expression is induced by a variety of stresses. For example, genotoxic and ER stresses as well as nutrient depletion can induce Gadd153 levels at both transcriptional and posttranscriptional levels (Luethy et al., 1990; Jackman et al., 1994; Wang et al., 1996; Bruhat et al., 1997; Sato et al., 2000) . Disruption of GADD153 gene has been shown to render cells more resistant to ER-stressinduced apoptosis, whereas exogenous Gadd153 is capable of inducing growth arrest and/or apoptosis (Barone et al., 1994; Matsumoto et al., 1996; Maytin et al., 2001) .
In this study, we have examined the role of Gadd153 in Ras-mediated oncogenic transformation. Our results demonstrate that oncogenic Ras downregulates Gadd153 protein and mRNA levels and it does so at least in part by decreasing the GADD153 mRNA stability. We further demonstrate that expression of exogenous Gadd153 in NIH3T3 cells suppresses oncogenic Ras-induced cellular transformation. Based on these novel findings, we propose that Gadd153 downregulation is an important mechanism via which Ras mediates cellular transformation.
To investigate the effect of oncogenic Ras on Gadd153 expression, we used NIH3T3 cells stably transfected with the oncogenic H-Ras V12 or R-Ras2/ TC21 expression vector (Huang et al., 1995) or empty control vector. We analysed untreated, cisplatin or thapsigargin-treated cells; cisplatin and thapsigargin induce genotoxic and ER stresses, respectively, and thus are known to upregulate Gadd153 expression (Luethy et al., 1990 , Wang et al., 1996 . As shown in Figure 1a , the Gadd153 protein levels are significantly reduced in cells expressing the oncogenic H-Ras V12 but the levels of c-Jun or b-actin are not affected. R-Ras2/TC21 is another oncogenic member of Ras superfamily that exhibits many effects similar to those mediated by oncogenic Ras including cellular transformation and activation of many redundant signaling events (Chan et al., 1994; Graham et al., 1994; Huang et al., 1995; Lopez-Barahona et al., 1996; Rosario et al., 1999; Rosario et al., 2001; Murphy et al., 2002; Rong et al., 2002) . We noted that, unlike oncogenic H-Ras that possesses strong suppressive effect on Gadd153 expression in untreated and stress-treated cells (Figure 1a ), RRas2/TC21 has minimal or no effect on Gadd153 expression (Figure 1a) . Thus, the facts that the expression levels of c-Jun protein remain unaffected under these experimental conditions and R-Ras2/TC21 sharing many similarities with Ras in terms of its oncogenic potential does not significantly affect Gadd153 levels ( Figure 1a ) highlight the specificity of Ras regulation of Gadd153. Next, we performed Northern blot analyses to investigate whether Ras-mediated downregulation of Gadd153 protein levels was coupled with concomitant decreases in GADD153 mRNA levels. As shown in Figure 1b , oncogenic Ras-expressing cells also exhibit reduced expression of GADD153 mRNA. Together, these results indicate that oncogenic Ras downregulates Gadd153 expression. Figure 2a shows the phenotypic changes induced by expression of the H-Ras V12 and RRas/TC21 in these cells. The H-Ras V12 and R-Ras2/ TC21-transformed cells are more spindle-shaped and refractile. These phenotypic changes, together with Western blot confirming the expression of H-Ras V12 ( Figure 2b ) and R-Ras2/TC21 , demonstrate the expression and functionality of these oncoproteins.
Previous studies have shown that GADD153 gene expression is regulated at both transcriptional and posttranscriptional levels (Bartlett et al., 1992; Choi et al., 1994; Jackman et al., 1994; Halleck et al., 1997; Ubeda et al., 1999; Kim et al., 2002) . As shown in Figure 1 , oncogenic Ras mediates Gadd153 downregulation at both mRNA and protein levels. Ras could potentially downregulate Gadd153 levels by decreasing the rate of GADD153 gene transcription and/or mRNA stability. To investigate the mechanism by which Ras downregulates GADD153 mRNA levels, we analysed the effect of oncogenic Ras on GADD153 mRNA stability. The relative rate of GADD153 mRNA decay was measured in vector-transfected and Ras-transfected NIH3T3 cells. As shown in Figure 3 , the GADD153 mRNA decays with a half-life of approximately 133 min in vector-transfected cells. In oncogenic Ras-expressing cells, however, the GADD153 mRNA half-life is approximately 55 min ( Figure 3 ). These results indicate that oncogenic Ras-mediated downregulation of Gadd153 occurs, at least in part, via post-transcriptional mechanism involving decreased mRNA stability. V12 and R-Ras2/TC21 NIH3T3 stable transfectants. Cells were either not treated or treated with cisplatin (8 mM) or thapsigargin (2 mM) for 24 h and harvested for Western blot analyses. Cell culture conditions, stable transfections and Western blot analyses were performed as we have previously described (Huang et al., 1995; Rong et al., 2002) . For Western analyses, a Gadd153-specific antibody (clone R20) purchased from Santa Cruz Biotechnology (CA, USA) was used. Same blot was sequentially probed with anti-c-Jun (Transduction Laboratories, KY, USA) and anti-b-actin (Sigma) antibodies. All protein signals were visualized using the enhanced chemiluminescence (ECL) system (Pierce, Amersham Biosciences, NJ, USA). (b) A representative Northern blot (of three independent experiments) showing GADD153 mRNA levels in vector-only and H-RasV12 transfectants. Northern blot analyses were performed by standard procedures as we have previously described (Huang et al., 2001) . To detect GADD153-specific signals, a human GADD153 cDNA probe was used (Park et al., 1992) ; ethidium bromide staining shows RNA integrity and comparable loading in each lane
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The Raf/MEK/ERK and PI3-K/Akt are two major signaling pathways responsible for transducing oncogenic Ras-mediated transformation signals. We therefore investigated whether these signaling pathways were involved in Ras-mediated suppression of Gadd153 expression. NIH3T3 stable transfectants harboring vector-only or oncogenic Ras were treated with MEK inhibitor PD98059 and PI3-K inhibitor LY294002 and approximately 24 h later cells were harvested and divided into two parts for analysis of Gadd153 protein and mRNA levels. We reasoned that if oncogenic Rasmediated downregulation of Gadd153 occurs via one or both of these kinase pathways, then the kinase-specific inhibitors should block or inhibit Ras-mediated suppression of Gadd153 expression. As shown in Figure 4a and b, both of these inhibitors did not prevent the oncogenic Ras-mediated downregulation of GADD153 mRNA or protein levels. Interestingly, the PI3-K inhibitor itself strongly downregulated Gadd153 at both mRNA and protein levels (Figure 4a , b, lane 5) and although the molecular basis of such an effect remains unclear and would require further investigation, our results clearly indicate that inhibition of both of these pathways did not prevent Ras downregulation of Gadd153. These results suggest that oncogenic Ras appears to mediate such effects via other novel mechanism(s).
Oncogenic Ras-mediated downregulation of Gadd153 could be an important event required for oncogenic Ras-induced cellular transformation. To gain further insight into this issue, we coexpressed Gadd153 with oncogenic Ras to elucidate whether exogenous Gadd153 would prevent oncogenic Ras-induced cellular transformation. We reasoned that if decreased levels of Gadd153 is a prerequisite for oncogenic Ras to successfully transform cells, then exogenously expressed Gadd153 should alter oncogenic Ras-induced cellular transformation. We used well-established foci formation assay as an indicator of cellular transformation to determine whether coexpression of Gadd153 along with oncogenic Ras could suppress Ras-induced foci formation and thus, cellular transformation. NIH3T3 cells were transfected with H-Ras V12 expression vector along with either the control vector-alone (pCEP4) or the pCEP4-GADD153 expression vector and foci formation was scored 20 days after antibiotic selections. As shown in Figure 5 and plus Gadd153-transfected cells ( Figure 5 and Table 1 ). Low levels of background (spontaneous) foci formation were observed in cells transfected with control vector alone ( Figure 5 and Table 1 ). NIH3T3 cells transfected with GADD153 expression vector without coexpression of oncogenic Ras were able to form a single layer of colonies, indicating that expression of Gadd153 did not cause significant cell death in these NIH3T3 cells (data The decay of GADD153 mRNA was determined by Northern blot hybridizations. The GADD153 mRNA levels at 0.5, 1, 2 and 4 h are plotted relative to time 0, which is defined as 100%. Values generally represent mean7s.e.m. of three independent experiments except for time 0.5 h which represents one experiment. The half-life of GADD153 mRNA was determined from the computergenerated curves as we have previously described (Sheikh et al., 1998; He et al., 2002) Downregulation of Gadd153 by Ras oncoprotein R Rong et al not shown). Expression of exogenous Gadd153 protein was confirmed by Western blot analysis in cells transfected with GADD153 expression vector (Figure 5b ). Together, these results demonstrate that expression of exogenous Gadd153 is able to impede oncogenic Ras-induced cellular transformation and thus, suggest that reduction in Gadd153 levels may be necessary for Ras-induced transformation to proceed. In total, we have shown in this study that expression of oncogenic Ras causes decreased expression of Gadd153 at both protein and mRNA levels. We have further demonstrated that oncogenic Ras-mediated downregulation of Gadd153 levels occurs, at least in part, via decreases in GADD153 mRNA stability. Our results also indicate that the expression of exogenous Gadd153 interferes with Ras-induced oncogenic transformation, which suggests that downregulation of this growth inhibitory/proapoptotic protein may be a key event in Ras-induced oncogenic transformation.
Cellular transformation is a complex process and involves a series of cellular and molecular changes. A large body of evidence indicates that several effector signaling pathways, including the Raf/MEK/ERK, RalGEF and PI3-K/Akt, are responsible for transducing the oncogenic Ras-mediated proliferative signals (reviewed in Campbell et al., 1998; Downward, 2003) . A number of transcription factors, including Elk, myc, fos and Jun that have growth stimulatory effects are known to reside downstream of these pathways. Recent evidence indicates that Ras also downregulates the expression of other proapoptotic molecules such as Par-4 and Bcl-2-family member Bak (Rosen et al., 1998; Barradas et al., 1999; Qiu et al., 1999) . Ectopic expression of Bak in Ras-transformed cells has been reported to inhibit Ras-induced tumorigenicity (Rosen et al., 1998) . Similarly, exogenous expression of the transcription repressor Par-4 has been reported to Foci formation assays were performed as we have previously described (Huang et al., 1995) with modifications. Cells were seeded in 100 mm plate at 50-70% confluency for overnight, and transfected with control vector pCEP4 (containing hygromycin-resistant marker) or pCEV29 (containing neomycin-resistant marker), and pCEP4-GADD153 or pCEV29-H-Ras V12 expression vectors in different combinations using LipofectAmine 2000 (Invitrogen, CA, USA) as per the manufacturer's protocol. Approximately 24 h after transfection, cells were coselected in both G418 (700 mg/ ml) and hygromycin B (150 mg/ml). The numbers of transformed foci on each culture dish were scored 2 weeks post-transfection. (b) Western blot analysis showing Gadd153 protein expression in Gadd153 transfectants. Increased levels of Gadd153 can been seen in cells expressing exogenous Gadd153 (lanes 2 and 4) over endogenously expressed Gadd153 NIH3T3 cells were cotransfected with the indicated vectors and selected with G418 (700 mg/ml) and hygromycin (150 mg/ml). The transformed foci were counted 20 days after transfection Downregulation of Gadd153 by Ras oncoprotein R Rong et al suppress oncogenic Ras-induced transformation. Par-4 is a proapoptotic transcription repressor that is upregulated during apoptosis induction, and etopic expression of par-4 sensitizes cells to stress-induced apoptosis (Diaz-Meco et al., 1996; Sells et al., 1997; Nalca et al., 1999) . Here, we report our novel findings that downregulation of Gadd153, a negative regulator of growth and survival, appears to be a key event during Rasinduced cellular transformation. Previous studies have shown that Gadd153 expression is strongly induced in response to stress and apoptosis-inducing conditions (Luethy et al., 1990; Luethy and Holbrook, 1992; Price and Calderwood, 1992) . Expression of exogenous Gadd153 has been shown to induce growth arrest (Barone et al., 1994; Matsumoto et al., 1996; Maytin et al., 2001) and to sensitize cells to ER stress-induced apoptosis (McCullough et al., 2001) . Gadd153 has been proposed to enhance cellular sensitivity to apoptosis via its ability to suppress the transcription of antiapoptotic Bcl-2 as well as by severely reducing intracellular glutathione production (GSH) (McCullough et al., 2001) . There is evidence to suggest that overexpression of Gadd153 also promotes mitochondria translocation of proapoptotic protein Bax (Gotoh et al., 2004) . Thus, elevated levels of Gadd153 may affect cellular survival via both transcription-dependent and -independent mechanisms. Recent evidence suggests that alteration in Gadd153 expression is also critical in c-myc-induced transformation. For example, c-myc-induced cellular transformation in rat-1 fibroblasts was also associated with downregulation of Gadd153 expression; expression of exogenous Gadd153 in c-myc-expressing cells prolonged cell doubling time (Chen et al., 1996) and blocked cell cycle progression from G1 to S phase (Barone et al., 1994) . Thus, Gadd153 is a key molecule whose downregulation may be a prerequisite for cellular transformation induced by oncogenes such as Ras and c-myc. Exactly how downregulation of Gadd153 might facilitate cellular transformation is an issue that would require future studies. Given that Gadd153 negatively modulates cell growth and survival, alterations in its expression and function are likely to have profound consequences. It is possible that oncogenic activation of the growth stimulatory signals, such as Raf/MEK/ERK, RalGEF and PI3-K/Akt, and suppression of growth inhibitory/proapoptotic signals, such as Bak, Par-4 and Gadd153, may occur simultaneously and contribute in concert to oncogenic transformation ( Figure 6 ). In this context, low levels of the growth inhibitory/proapoptotic molecules would prove crucial for the initiation and maintenance of oncogenic transformation. 
